We can all picture that moment in clinic: you are about to tell someone that they’re no longer legally able to drive, ready to deploy our ‘breaking bad news’ techniques. For some patients this may have been expected, or they...
1–3 March 2025 • London, UK • Register here March 2025 will see the second instalment of 100% Ophthalmology which, if you were following us last year, was a great success. Co-located alongside the well-known 100% Optical and hosted within...
A 40-year-old company executive is referred from another unit with recurrent anterior and posterior uveitis for 12 months and the inflammatory markers are raised. Review of systems This is a case of chronic uveitis which needs a thorough workup and...
Nicola Killean, Children and Young People’s Commissioner Scotland, has praised Sight Scotland for not only upholding the rights of visually impaired children and young people, but also empowering them to know their own rights so they can shape their own educational journey.
Glaucoma UK has announced the appointments of the new President and President-elect for the UK and Éire Glaucoma Society (UKEGS). Taking over from Ms Nishani Amerasinghe, the 2025 President is Dr Andrew Tatham who is a consultant at Princess Alexandra...
Charity SeeAbility and Willow Dene Oakmere Road special school in Greenwich were delighted to host the first practising optometrist MP to be elected to parliament, Shockat Adam, to see the charity’s eyecare work in action. Shockat came to learn more...
We’re always ecstatic when one of our media partners bring their conference to Scotland, especially when they land in our hometown of Edinburgh. Taking place in The Assembly Rooms, a beautiful 18th century venue in the heart of Edinburgh’s New...
Medical electives are an excellent opportunity to learn, enjoy and explore countries and their healthcare systems. I was grateful to do mine in ophthalmology at Harvard Medical School (HMS). This article will share my personal experience working at HMS with...
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...